SCHEMBL6238924

SCHEMBL6238924

C=C(C(=O)O)C1=CCc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.34
SRD5A1 P18405 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
MITF O75030 1/20 0.33
HSP90AA1 P07900 1/20 0.33
RAB9A P51151 1/20 0.33
HTR6 P50406 1/20 0.33
KDM4E B2RXH2 3/20 0.32
LMNA P02545 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
NOTUM Q6P988 1/20 0.32
MAOA P21397 2/20 0.31
CES1 P23141 1/20 0.31
TSHR P16473 3/20 0.31
ALOX15 P16050 2/20 0.31
SIRT1 Q96EB6 1/20 0.31
MAOB P27338 1/20 0.31
XIAP P98170 1/20 0.30
HKDC1 Q2TB90 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31147237 0.83 SRD5A2 (0.43) SRD5A2SRD5A1SMN1; SMN2HTR6KDM4E
SCHEMBL335207 0.83 SRD5A2 (0.43) SRD5A2SRD5A1SMN1; SMN2HTR6KDM4E
SCHEMBL11813906 0.79 HTR6 (0.37) SRD5A2SRD5A1SMN1; SMN2HTR6ALDH1A1
SCHEMBL3614858 0.77 RNASEH1 (0.36) SRD5A2SRD5A1SMN1; SMN2HTR6ALDH1A1
SCHEMBL8678690 0.76 MEN1 (0.35) SRD5A2SRD5A1SMN1; SMN2HTR6
SCHEMBL23079026 0.76 HTR6 (0.35) SRD5A2SRD5A1SMN1; SMN2HTR6KDM4E
SCHEMBL21694461 0.76 ALDH1A1 (0.35) RAB9AHTR6ALDH1A1NOTUMMAOA
SCHEMBL4527055 0.76 HTR6 (0.35) SRD5A2SRD5A1SMN1; SMN2HTR6KDM4E
SCHEMBL23073778 0.76 HTR6 (0.39) SMN1; SMN2HTR6KDM4EALDH1A1NOTUM
SCHEMBL4527060 0.76 NOTUM (0.40) SMN1; SMN2RAB9AHTR6KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-B1 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL INC (US) 2005-06-29 EP disclosed